Filing Details

Accession Number:
0001140361-16-085046
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-11-07 14:20:56
Reporting Period:
2016-11-03
Filing Date:
2016-11-07
Accepted Time:
2016-11-07 14:20:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1335103 Protea Biosciences Group Inc. PRGB Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1529364 Stanley Hostler 1311 Pineview Drive, Suite 501
Morgantown WV 26505
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-03 293,333 $0.08 2,724,992 No 4 P Indirect By spouse
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By spouse
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Class A Warrant to Purchase Common Stock Acquisiton 2016-11-03 293,333 $0.08 293,333 $0.09
Common Stock Class B Warrant to Purchase Common Stock Acquisiton 2016-11-03 293,333 $0.08 293,333 $0.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
293,333 2016-11-03 2017-05-03 No 4 A Indirect
293,333 2016-11-03 2021-11-03 No 4 A Indirect
Footnotes
  1. The spouse of Reporting Person purchased 2.2 Units of the Issuer's securities for an aggregate purchase price of $22,000, each Unit consisting of (a) 133,333.33 shares of common stock, par value $0.0001 per share (the "Common Stock"), (b) 18 month warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.09 per share (the "Class A Warrants"), and (c) five year warrants to purchase up to 133,333.33 shares of Common Stock at an exercise price of $0.1125 per share (the "Class B Warrants").